ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Novavax Inc

Novavax Inc (NVV1)

8.426
-0.032
( -0.38% )
Updated: 03:45:45
Realtime Data

Novavax Inc Financial Summary

The current NVV1 market cap is 1B. The company's latest EPS is USD -4.5885 and P/E is -1.95.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 18.66M475.6M1.15B1.98B983.71M
Operating Income -129.6M-416.72M-1.69B-644.74M-566.51M
Net Income -132.69M-418.26M-1.74B-657.94M-545.06M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 172.96M1.58B2.58B2.26B1.8B
Total Liabilities 358.97M955.27M2.93B2.89B2.51B
Total Equity -186.02M627.21M-351.67M-634.08M-716.93M

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -136.62M-42.54M322.95M-415.94M-713.97M
Investing 38.49M-377.78M100.15M-92.99M-58.81M
Financing 98.38M984.76M461.71M324.99M4.47M
Market Cap 1B
Price to Earnings Ratio -1.95
Price to Sales Ratio 1.08
Price to Cash Ratio 1.87
Price to Book Ratio -1.48
Dividend Yield -

Share Statistics

Shares Outstanding 118.79M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.08 (0.96%)

Company Info

Company Name Novavax Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.novavax.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock